Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Discover proven strategies to grow small investments. Learn how to make the most of your financial resources effectively.
19,213 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
As AI accelerates, investors wonder if Sandisk could become the next Nvidia. This article dives into Sandisk's AI-sto...
When avis budget group stock drops, it signals more than a single quarterly miss. This guide breaks down the forces a...
NVIDIA doubles down on its OpenAI investment strategy to secure GPU demand and influence the AI software stack, a mov...
Salesforce stock faces a pivotal year as AI-enhanced CRM and cloud strategy shape the upside. Here's the latest marke...
The co-author behind a viral AI disruption post says he was shorting the stocks he described, adding another layer to...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
Intel's shares have surged about 90% in the past year, but the real test lies in whether this comeback can endure thr...
A disciplined four-stock plan turns $10,000 into a steady income stream, backed by steady brands and durable cash flo...
TeraWulf releases Q4 2025 results after the bell, signaling a shift from Bitcoin mining to AI compute. After-hours tr...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...
The founder is back at Simply Good Foods, triggering a shift in market mood as insiders buy and Reddit chatter tilts ...